Cellular, Molecular and Biomedical Reports

Biosafety Society of Iran

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Publication Ethics and Malpractice Statement

Ethical Oversight

Open Access Policy, and Assignment - CC BY

Repository policy

Publisher’S Note

Informed Consent

Guiding Principles for Research Involving Animals and Human Beings

Compliance with Ethical Standards

Copyright and license

CrossMark Policy

Journal Metrics

FAQ

News

Related Links

Responsibility of the Editor

Editorial Policies (Appeals and Complaints)

Guidelines for Guest Editors

Web of Science Profile (for Editing)

Reviewers

Responsibility of Reviewers

Peer Review Process

Peer Review Policy

Web of Science Profile (for reviewing)

Instructions for Authors

Responsibility of the Author

Plagiarism and Similarity Rates

Responding to Allegations of Possible Misconduct

Responses to Possible Misconduct

Permanency of Articles

Data Sharing Policy

Data Citation

Article Processing Charges and Publication Fee

Authors Benefits

Practical Guide to the SI Units

Structural carcinoma overall process: a systematic review

Document Type : Meta Analysis

Authors

1 Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

2 Division of Neurology, School of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE

3 Department of Neuro Sciences, School of Medicine, Shahid Beheshti University Medical of Science, Tehran, Iran

4 Department of Neuro Sciences, School of Medicine, Tehran University Medical of Science, Tehran, Iran

5 Department of Neuro Sciences, School of Medicine, Iran University Medical of Science, Tehran, Iran

Abstract

Abnormalities of several oncogenes and tumor suppressor genes have been identified in carcinomas during the last decade and of pathological warfare and physiological traits, and multiple genetic changes have been demonstrated in individual carcinomas. We conducted a systematic review of studies enrolling adolescents and adults with Carcinoma, every type in which a cancer intervention was randomized, or all study designs in which there was a primary or secondary outcome. We searched Ovid MEDLINE, EMBASE, and Evidence-Based Medicine Reviews from 1990 to June 2015. Two reviewers evaluated study eligibility and abstracted data. In total, 67 studies were included and consisted of 62 randomized trials, reviews, and 5 studies. None of the studies (0/81) provided a definition. Only one randomized trial provided a definition. We were unable to identify any definitions used in studies of adolescents and adults with Carcinoma. Given that a proportion of this population may receive intensive treatment, there is an urgent need for consensus-based definitions of use across trials and review systematic & and meta-analysis.

Graphical Abstract

Structural carcinoma overall process: a systematic review

Keywords

Main Subjects

Full Text

Selected author of this article by journal

Dr. Ali Reza Arabestanino
Harvard Medical School

Google Scholar

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

 

Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.

 

Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

References
  1. Chatterjee D, Costa CAM, Wang XF, Jevitt A, Huang YC, Deng WM (2022) Single-cell transcriptomics identifies Keap1-Nrf2 regulated collective invasion in a Drosophila tumor model. Elife 11. doi: https://doi.org/10.7554/eLife.80956
  2. Ferone G, Lee MC, Sage J, Berns A (2020) Cells of origin of lung cancers: lessons from mouse studies. Genes Dev 34 (15-16): 1017-1032. doi: https://doi.org/10.1101/gad.338228.120
  3. Galfiova P, Polak S, Mikusova R, Jurikova M, Klein M, Csobonyeiova M, Danisovic L, Varga I (2022) Scanning electron microscopic study of the human uterine tube epithelial lining: surgical biopsy samples and epithelial cell culture. Physiological research 71 (Suppl 1): S137-s144. doi: https://doi.org/10.33549/physiolres.935031
  4. Sacchetti A, Teeuwssen M, Verhagen M, Joosten R, Xu T, Stabile R, van der Steen B, Watson MM, Gusinac A, Kim WK, Ubink I, Van de Werken HJ, Fumagalli A, Paauwe M, Van Rheenen J, Sansom OJ, Kranenburg O, Fodde R (2021) Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. Elife 10. doi: https://doi.org/10.7554/eLife.61461
  5. Hong ZL, Huang HJ, Chen S, Yang JC, Wu SS (2023) Case Report: A tortuous diagnosis and successful multimodal treatment of thyroid follicular carcinoma with pelvic metastasis. Front Oncol 13: 1048485. doi: https://doi.org/10.3389/fonc.2023.1048485
  6. Qi P, Bai QM, Yao QL, Yang WT, Zhou XY (2020) Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay. Technol Cancer Res Treat 19: 1533033820960760. doi: https://doi.org/10.1177/1533033820960760
  7. Rusu CB, Gorbatai L, Szatmari L, Koren R, Bungardean CI, Feciche BO, Bumbulut C, Andras IM, Rahota R, Telecan T, Coman I, Rath-Wolfson L, Crisan N (2020) Leiomyosarcoma of the inferior vena cava. Our experience and a review of the literature. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 61 (1): 227-233. doi: https://doi.org/10.47162/rjme.61.1.25
  8. Sindiani A, Obeidat B, Hamadeh L, Alghazo S, Al-Mohtaseb A, Alshdaifat E (2020) A descriptive study of the clinico-pathological and surgical characteristics of patients with primary epithelial ovarian cancer. A cross sectional study. Annals of medicine and surgery (2012) 59: 254-257. doi: https://doi.org/10.1016/j.amsu.2020.09.043
  9. Kato T, Ono Y, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y (2023) Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: The importance of T status with regard to the prognosis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 49 (1): 122-128. doi: https://doi.org/10.1016/j.ejso.2022.08.005
  10. Lauricella S, Caricato M, Masciana G, Carannante F, Carnazza M, Bonaccorso A, Angeletti S, Ciccozzi M, Coppola R, Capolupo GT (2020) Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience. Surgical oncology 34: 223-233. doi: https://doi.org/10.1016/j.suronc.2020.04.022
  11. Qin F, Pang H, Yu T, Luo Y, Dong Y (2022) Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review. Technol Cancer Res Treat 21: 15330338221086403. doi: https://doi.org/10.1177/15330338221086403
  12. Jain N, Nagaich U, Pandey M, Chellappan DK, Dua K (2022) Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements. The EPMA journal 13 (4): 561-580. doi: https://doi.org/10.1007/s13167-022-00304-2
  13. Mamic P, Snyder M, Tang WHW (2023) Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol 81 (17): 1729-1739. doi: https://doi.org/10.1016/j.jacc.2023.02.045
  14. Miskiewicz J, Mielczarek-Palacz A, Gola JM (2023) MicroRNAs as Potential Biomarkers in Gynecological Cancers. Biomedicines 11 (6). doi: https://doi.org/10.3390/biomedicines11061704
  15. Fazeli-Nasab B, Bidarnamani F (2022) Medicinal Plants and Herbal Compounds: Cancer Prevention and Treatment. Plant Biotechnology Persa 4 (1): 25-35. doi:
  16. Fazeli-Nasab B, Sayyed RZ, Sobhanizadeh A (2021) In Silico Molecular Docking Analysis of α-Pinene: An Antioxidant and Anticancer Drug Obtained from Myrtus communis. Int J Cancer Manag 14 (2): e89116. doi: https://doi.org/10.5812/ijcm.89116
  17. Azdajic MD, Beslic I, Gasic A, Ferara N, Pedic L, Lugovic-Mihic L (2022) Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show? Life (Basel, Switzerland) 12 (10). doi: https://doi.org/10.3390/life12101598
  18. Reid KM, Martin LJ, Heathfield LJ (2023) Understanding the burden of unidentified bodies: a systematic review. International journal of legal medicine 137 (4): 1193-1202. doi: https://doi.org/10.1007/s00414-023-02968-5
  19. Verbraecken J, Dieltjens M, Op de Beeck S, Vroegop A, Braem M, Vanderveken O, Randerath W (2022) Non-CPAP therapy for obstructive sleep apnoea. Breathe (Sheffield, England) 18 (3): 220164. doi: https://doi.org/10.1183/20734735.0164-2022
  20. Adelsmayr G, Janisch M, Muller H, Holzinger A, Talakic E, Janek E, Streit S, Fuchsjager M, Schollnast H (2023) Three dimensional computed tomography texture analysis of pulmonary lesions: Does radiomics allow differentiation between carcinoma, neuroendocrine tumor and organizing pneumonia? European journal of radiology 165: 110931. doi: https://doi.org/10.1016/j.ejrad.2023.110931
  21. Jansen K, Farahi N, Buscheck F, Lennartz M, Luebke AM, Burandt E, Menz A, Kluth M, Hube-Magg C, Hinsch A, Hoflmayer D, Weidemann S, Fraune C, Moller K, Lebok P, Sauter G, Simon R, Uhlig R, Wilczak W, Jacobsen F, Minner S, Krech R, Clauditz T, Bernreuther C, Dum D, Krech T, Marx A, Steurer S (2021) DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. Pathology, research and practice 228: 153663. doi: https://doi.org/10.1016/j.prp.2021.153663
  22. Sapuppo E, Brunetti O, Tessitore D, Brandi G, Di Giovanni N, Fadda G, Luchini C, Martini M, Quaresmini D, Russo A, Santarpia M, Scarpa A, Scartozzi M, Tuccari G, Franchina T, Silvestris N (2023) Rare histotypes of epithelial biliary tract tumors: A literature review. Crit Rev Oncol Hematol 181: 103892. doi: https://doi.org/10.1016/j.critrevonc.2022.103892
  23. Yang Y, Sun JD, Xiang ZL (2023) Pan-cancer analysis of the oncogenic role of HNRNPR in human tumors. Cell Biol Int 47 (8): 1406-1426. doi: https://doi.org/10.1002/cbin.12027
  24. Majumder A, Phulware RH, Ahuja A, Singla A, Kumar P (2021) Renal angiomyoadenomatous tumor (RAT): a rare distinct entity with diagnostic challenges-a case report. Journal of the Egyptian National Cancer Institute 33 (1): 1. doi: https://doi.org/10.1186/s43046-020-00056-y
  25. Bremmer F, Lubk L, Strobel P, Nettersheim D (2023) Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation. Histopathology 83 (3): 477-481. doi: https://doi.org/10.1111/his.14933
  26. Zhu Y, Yin Y, Li F, Ren Z, Dong Y (2023) A review on the oncogenesis of Merkel cell carcinoma: Several subsets arise from different stages of differentiation of stem cell. Medicine (Baltimore) 102 (15): e33535. doi: https://doi.org/10.1097/md.0000000000033535
  27. Trotz C (2003) Prostate cancer with a normal PSA: small cell carcinoma of the prostate–a rare entity. The Journal of the American Board of Family Practice 16 (4): 343-344. doi: https://doi.org/10.3122/jabfm.16.4.343
  28. Hoang MP, Maitra A, Gazdar AF, Albores-Saavedra J (2001) Primary mammary small-cell carcinoma: A molecular analysis of 2 cases. Human Pathology 32 (7): 753-757. doi: https://doi.org/10.1053/hupa.2001.25603
  29. Rossi G, Bertolini F, Sartori G, Bigiani N, Cavazza A, Foroni M, Valli R, Rindi G, De Gaetani C, Luppi G (2004) Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. The American journal of surgical pathology 28 (9): 1233-1239. doi: https://doi.org/10.1097/01.pas.0000128666.89191.48
  30. Canda M (2017) New histopathological diagnostic terms and their codes of the central nervous system (CNS) in the international classification of diseases for oncology (ICD-O 3.1) and about the Turkish version of ICD-O. J Cancer Diagn 2 (112): 2253-2476.
  31. Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. The Lancet 379 (9824): 1428-1435. doi: https://doi.org/10.1016/S0140-6736(11)61178-1
  32. Hung D, Lenton D, Eslick R, Blennerhassett R, Joshi M, McCaughan G, Day S, Wright D (2021) Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma. Genes, chromosomes & cancer 60 (10): 668-677. doi: https://doi.org/10.1002/gcc.22975
  33. Li C, Liu Z, Zhang X, Wang H, Friedman GK, Ding Q, Zhao X, Li H, Kim K, Yu X, Burt Nabors L, Han X, Zhao R (2022) Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing. Neuro-oncology advances 4 (1): vdac131. doi: https://doi.org/10.1093/noajnl/vdac131
  34. Wang T, Ren C, Chen D, Lu J, Guo L, Zheng L, Liu Y, Chen H (2019) Prenatal diagnosis of Pallister-Killian syndrome using cord blood samples. Molecular cytogenetics 12: 39. doi: https://doi.org/10.1186/s13039-019-0449-x
  35. Mishra D, Mishra A, Rai SN, Vamanu E, Singh MP (2023) Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis. Diagnostics (Basel, Switzerland) 13 (5). doi: https://doi.org/10.3390/diagnostics13050965
  36. Winnard PT, Jr., Morsberger L, Yonescu R, Jiang L, Zou YS, Raman V (2023) Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. Cancers (Basel) 15 (5). doi: https://doi.org/10.3390/cancers15051420
  37. Hainsworth JD, Lennington WJ, Greco FA (2000) Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site. Journal of clinical oncology 18 (3): 632-632. doi: https://doi.org/10.1200/JCO.2000.18.3.632
  38. Hillen HF, Hak LE, Joosten‐Achjanie SR, Arends JW (1997) Microvessel density in unknown primary tumors. International journal of cancer 74 (1): 81-85. doi: https://doi.org/10.1002/(SICI)1097-0215(19970220)74:1%3C81::AID-IJC14%3E3.0.CO;2-L
  39. Karavasilis V, Malamou‐Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N (2005) Matrix metalloproteinases in carcinoma of unknown primary. Cancer: Interdisciplinary International Journal of the American Cancer Society 104 (10): 2282-2287. doi: https://doi.org/10.1002/cncr.21454
  40. Shah E, Abro C (2022) Metastatic Extrapulmonary Small Cell Carcinoma Presenting as Obstructive Jaundice. Case Reports in Oncology 15 (2): 668-673. doi: https://doi.org/10.1159/000525279
  41. Sait AA, Patel U, Berilgen J, Mani S (2023) A Case Report on Initial Experience of Lattice Radiation Therapy for Managing Massive Non-small Cell Lung Cancer and Renal Pelvic Cancer. Cureus 15 (9): e44764. doi: https://doi.org/10.7759/cureus.44764
  42. Hasanzadeh M, Babapour N, Farazestanian M, Torshizi FHN (2020) Small Cell Neuroendocrine Cervical Carcinoma: A Case Report. Journal of Family & Reproductive Health 14 (4): 273-275. doi: https://doi.org/10.18502%2Fjfrh.v14i4.5212
  43. Brazg Ferro L, Wolf I, Peleg Hasson S, Golomb I, Osher E, Berlin A, Gutfeld O, Ospovat I, Soyfer V (2021) Extrapulmonary small cell cancer: a new insight into a rare disease. Oncology 99 (6): 373-379. doi: https://doi.org/10.1159/000514520
  44. Walenkamp AME, Sonke GS, Sleijfer DT (2009) Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treatment Reviews 35 (3): 228-236. doi: https://doi.org/10.1016/j.ctrv.2008.10.007
  45. Corder BN, Grenn EE, Orr WS, 3rd (2022) Late Diagnosis of Metastatic Leiomyosarcoma Originating in the Ureter. The American surgeon 88 (9): 2265-2266. doi: https://doi.org/10.1177/00031348221091972
  46. van Beers MA, Schreuder WH, Balm AJM, van Dijk BAC (2023) Is locally advanced head and neck cancer 'increasing' in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share. Oral oncology 138: 106316. doi: https://doi.org/10.1016/j.oraloncology.2023.106316
  47. van der Heijden HF, Heijdra YF (2005) Extrapulmonary small cell carcinoma. Southern medical journal 98 (3): 345-350. doi:
  48. Kavuri SK, Ullah A, Iyoha E, Ballur K, Gilstrap L, Mattox SN (2022) Oncocytic Papillary Cystadenoma, an Unusual Variant Presenting as a Laryngeal Ventricular Cyst. Current health sciences journal 48 (3): 353-355. doi: https://doi.org/10.12865/chsj.48.03.15
  49. Palic J, Heier A, Wohlsein P (2022) Cytologic features of an acanthomatous ameloblastoma in a dog. Veterinary clinical pathology 51 (2): 258-262. doi: https://doi.org/10.1111/vcp.13080
  50. Yamada M, Otsuki Y, Ikeya T, Shimizu SI, Tanioka F, Ogawa H, Kobayashi H (2023) Cytological study of 44 cases with solid papillary carcinoma and a systemic review of solid papillary carcinoma and neuroendocrine tumor of the breast. Diagnostic cytopathology 51 (6): 341-348. doi: https://doi.org/10.1002/dc.25112
  51. Lotowska JM, Sobaniec-Lotowska ME, Bobrus-Chociej A, Sobaniec P (2023) The Ultrastructure of Hepatic Stellate Cell-Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis. J Clin Med 12 (3). doi: https://doi.org/10.3390/jcm12031024
  52. Sergi CM, Patry J, Coenraad H, McClintock J, Nicholls R, Steiner HJ, Mikuz G (2022) Transmission Electron Microscopy: A Surgical Pathology Tool for Neuroblastoma. Journal of visualized experiments : JoVE(185). doi: https://doi.org/10.3791/63994
  53. Grimaldi F, Bonasoni MP, Pelletti G, Gabrielli L, Pelotti S (2023) Diagnostic challenges and forensic implications in a case of infantile fatal myocarditis. Forensic science, medicine, and pathology. doi: https://doi.org/10.1007/s12024-023-00659-6
  54. Weekman EM, Winder Z, Rogers CB, Abner EL, Sudduth TL, Patel E, Dugan AJ, Fister SX, Wasek B, Nelson PT, Jicha GA, Bottiglieri T, Fardo DW, Wilcock DM (2022) Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue. Alzheimer's & dementia (New York, N Y) 8 (1): e12368. doi: https://doi.org/10.1002/trc2.12368
  55. Tot T (2002) Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. European Journal of Cancer 38 (6): 758-763. doi: https://doi.org/10.1016/S0959-8049(02)00008-4
  56. Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN (2005) Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clinical Cancer Research 11 (10): 3766-3772. doi: https://doi.org/10.1158/1078-0432.CCR-04-2236
  57. Karsell PR, Sheedy PF, O'Connell MJ (1982) Computed tomography in search of cancer of unknown origin. Jama 248 (3): 340-343. doi: https://doi.org/10.1001/jama.1982.03330030046024
  58. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of an unknown primary. European Journal of Cancer 39 (14): 1990-2005. doi: https://doi.org/10.1016/S0959-8049(03)00547-1
  59. Shimoda M, Mellody KT, Orimo A (2010) Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Seminars in cell & developmental biology 21 (1): 19-25. doi: https://doi.org/10.1016/j.semcdb.2009.10.002
  60. Bian C, Su J, Zheng Z, Wei J, Wang H, Meng L, Xin Y, Jiang X (2022) ARTS, an unusual septin, regulates tumorigenesis by promoting apoptosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 152: 113281. doi: https://doi.org/10.1016/j.biopha.2022.113281
  61. Zhao F, Zhang L, Wei M, Duan W, Wu S, Kasim V (2022) Mechanosensitive Ion Channel PIEZO1 Signaling in the Hall-Marks of Cancer: Structure and Functions. Cancers (Basel) 14 (19). doi: https://doi.org/10.3390/cancers14194955
  62. Stolnicu S, Soslow RA (2022) Squamous and Glandular Epithelial Tumors of the Cervix: A Pragmatical Review Emphasizing Emerging Issues in Classification, Diagnosis, and Staging. Surgical pathology clinics 15 (2): 369-388. doi: https://doi.org/10.1016/j.path.2022.02.010
  63. Sung JA, Nikas IP, Kim H, Ryu HS, Lee C (2022) Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study. Journal of pathology and translational medicine 56 (6): 354-360. doi: https://doi.org/10.4132/jptm.2022.09.05
  64. Wasinger G, Oszwald A, Shariat SF, Comperat E (2022) Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes. Current opinion in urology 32 (6): 643-648. doi: https://doi.org/10.1097/mou.0000000000001038
  65. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151 (4): 264-269. doi: https://doi.org/10.7326/0003-4819-151-4-200908180-00135
  66. Ahtela E, Oksi J, Porela P, Ekstrom T, Rautava P, Kyto V (2019) Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland. BMJ Open 9 (4): e026811. doi: https://doi.org/10.1136/bmjopen-2018-026811
  67. Katsumi T, Ueno Y (2022) Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver international : official journal of the International Association for the Study of the Liver 42 (9): 2015-2022. doi: https://doi.org/10.1111/liv.15155
  68. Nagele H, Groene E, Stierle D, Nagele MP (2021) Analysis of causes of death in patients with implanted defibrillators. Clinical research in cardiology : official journal of the German Cardiac Society 110 (6): 895-904. doi: https://doi.org/10.1007/s00392-021-01825-y
  69. Rekhi B, Menon S, Deodhar KK, Ghosh J, Chopra S, Maheshwari A (2020) Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India. Annals of diagnostic pathology 47: 151558. doi: https://doi.org/10.1016/j.anndiagpath.2020.151558
  70. Walker-Bone K, Benke G, MacFarlane E, Klebe S, Takahashi K, Brims F, Sim MR, Driscoll TR (2023) Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry. Occup Environ Med 80 (4): 186-191. doi: https://doi.org/10.1136/oemed-2022-108669
  71. Yang DD, Borsky K, Jani C, Crowley C, Rodrigues JN, Matin RN, Marshall DC, Salciccioli JD, Shalhoub J, Goodall R (2023) Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. The British journal of dermatology 188 (2): 237-246. doi: https://doi.org/10.1093/bjd/ljac064
  72. Jasieniak J, Kuchcinska A, Podgorska J, Cieszanowski A (2023) Summary of radiation dose management and optimization: comparison of radiation protection measures between Poland and other countries. Polish journal of radiology 88: e12-e21. doi: https://doi.org/10.5114/pjr.2023.124376
  73. Khan AJJ, Khan NAJ (2020) High-Grade Malignant Spindle Cell Sarcoma of the Pelvis Presenting With Bloody Diarrhea and Urinary Retention: A Rare Case With a Rare Presentation. Cureus 12 (9): e10622. doi: https://doi.org/10.7759/cureus.10622
  74. Mamootil D (2023) Pediatric Ulcerative Colitis in Siblings. Cureus 15 (6): e40829. doi: https://doi.org/10.7759/cureus.40829
  75. McCray E, Naron R, White S, Messersmith S, Stewart C (2021) Metastatic Breast Cancer Masked as Constipation. Cureus 13 (6): e16031. doi: https://doi.org/10.7759/cureus.16031
  76. Sousa AC, Santos JC, Landolt C, Gomes C, Dias-Pereira P, Baptista CS (2020) Clinicopathological and imaging features of pulmonary alveolar microlithiasis in a dog - a case report. BMC Vet Res 16 (1): 376. doi: https://doi.org/10.1186/s12917-020-02593-z
Cellular, Molecular and Biomedical Reports
Volume 4, Issue 2
Cellular, Molecular and Biomedical Reports (Online ISSN: 2823-2550)
June 2024
Pages 88-99
Files
History
  • Receive Date: 11 May 2023
  • Revise Date: 03 July 2023
  • Accept Date: 09 September 2023
Share
How to cite
Statistics